Related Experiment Video
Updated: Jun 27, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Systemic Therapy for Advanced-Stage Hodgkin Lymphoma
Varun Iyengar1, Kishan Patel1, Alison Moskowitz1
1Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancers
|June 26, 2026
Summary
Frontline therapy for advanced classic Hodgkin lymphoma (cHL) has evolved from chemotherapy to targeted treatments, improving survival rates. Current strategies balance efficacy and toxicity reduction for better patient outcomes.
Area of Science:
- Oncology
- Hematology
- Clinical Therapeutics
Background:
- Advanced-stage classic Hodgkin lymphoma (cHL) survival has significantly improved, exceeding 80% long-term survival.
- Treatment has evolved from early chemotherapy regimens to modern, biologically informed strategies.
Purpose of the Study:
- To review the evolution of frontline therapy for advanced-stage cHL.
- To examine the transition from empiric chemotherapy to contemporary, biologically informed treatment strategies.
- To discuss the integration of novel agents and future directions.
Main Methods:
- Review of historical and contemporary treatment approaches for advanced-stage cHL.
- Analysis of chemotherapy regimens (MOPP, ABVD, BEACOPP).
- Evaluation of PET-adapted therapy and novel agents (brentuximab vedotin, PD-1 blockade).
Main Results:
- Early chemotherapy regimens (MOPP, ABVD) established curability of advanced lymphoma.
- Treatment intensification (BEACOPP) improved disease control but increased toxicity.
- PET-adapted therapy and novel agents enhance outcomes and reduce toxicity.
Conclusions:
- Frontline therapy for advanced cHL has shifted from maximizing cytotoxic intensity to personalized strategies.
- Novel agents and biomarker-driven approaches are refining treatment to optimize cure and minimize harm.
- Future research focuses on risk stratification and circulating tumor DNA for further treatment refinement.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...